Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard A Morgan

Showing results (1-10 of 129) with videos related to

Pageof 13
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2012
Human tumor xenografts: the good, the bad, and the uglyRichard A Morgan
Blood|November 16, 2013
Risky business: target choice in adoptive cell therapyRichard A Morgan
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2012
Live and let die: a new suicide gene therapy moves to the clinicRichard A Morgan
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Faster, cheaper, safer, T-cell engineeringRichard A Morgan
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2014
Boolean immunotherapy: reversal of fortuneRichard A Morgan
Biomedicines|May 25, 2017
Genetic Modification of T CellsRichard A Morgan, Benjamin Boyerinas
Methods in Molecular Medicine|January 16, 2003
Semliki Forest virus vectors for gene transferJarmo Wahlfors, Richard A Morgan
Advanced Drug Delivery Reviews|December 20, 2011
Genetic engineering with T cell receptorsLing Zhang, Richard A Morgan
Methods in Molecular Medicine|May 4, 2002
Minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system. Production and useJarmo Wahlfors, Richard A Morgan
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Genetic modification of T cellsRichard A Morgan, Sunitha Kakarla
Pageof 13

Showing results (1-10 of 129) with videos related to

Sort By:
Pageof 13
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 3, 2012
Human tumor xenografts: the good, the bad, and the uglyRichard A Morgan
Blood|November 16, 2013
Risky business: target choice in adoptive cell therapyRichard A Morgan
Molecular Therapy : the Journal of the American Society of Gene Therapy|February 10, 2012
Live and let die: a new suicide gene therapy moves to the clinicRichard A Morgan
Journal of Immunotherapy (Hagerstown, Md. : 1997)|December 6, 2012
Faster, cheaper, safer, T-cell engineeringRichard A Morgan
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 3, 2014
Boolean immunotherapy: reversal of fortuneRichard A Morgan
Biomedicines|May 25, 2017
Genetic Modification of T CellsRichard A Morgan, Benjamin Boyerinas
Methods in Molecular Medicine|January 16, 2003
Semliki Forest virus vectors for gene transferJarmo Wahlfors, Richard A Morgan
Advanced Drug Delivery Reviews|December 20, 2011
Genetic engineering with T cell receptorsLing Zhang, Richard A Morgan
Methods in Molecular Medicine|May 4, 2002
Minigene-containing retroviral vectors using an alphavirus/retrovirus hybrid vector system. Production and useJarmo Wahlfors, Richard A Morgan
Cancer Journal (Sudbury, Mass.)|March 27, 2014
Genetic modification of T cellsRichard A Morgan, Sunitha Kakarla
Pageof 13